| Serial Number | 90749349 |
| Word Mark | A LIFE IN MOTION BEGINS WITH LESS MIGRAINE |
| Filing Date | Wednesday, June 2, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Wednesday, May 8, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 22, 2022 |
| Goods and Services | printed materials, namely, pamphlets, brochures, booklets, leaflets, informational flyers, informational sheets and newsletters relating to the treatment of migraines |
| Goods and Services | Providing medical information relating to the treatment of migraines |
| International Class | 016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks. |
| US Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 16, 2022 |
| Primary Code | 016 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 25, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Teva Pharmaceuticals International GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JONA 8645 CH |
| Party Name | Teva Pharmaceuticals International GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JONA 8645 CH |
| Event Date | Event Description |
| Saturday, June 5, 2021 | NEW APPLICATION ENTERED |
| Wednesday, August 25, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 16, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, February 16, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, February 16, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 16, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 16, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, February 16, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 2, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 22, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 22, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 17, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, November 9, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 9, 2022 | SOU EXTENSION 1 FILED |
| Wednesday, November 9, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, November 11, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 2, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 2, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, May 2, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, May 4, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 9, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 9, 2023 | SOU EXTENSION 3 FILED |
| Thursday, November 9, 2023 | SOU EXTENSION 3 GRANTED |
| Saturday, November 11, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 8, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 8, 2024 | SOU EXTENSION 4 FILED |
| Wednesday, May 8, 2024 | SOU EXTENSION 4 GRANTED |
| Thursday, May 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 13, 2024 | SOU TEAS EXTENSION RECEIVED |